Loading organizations...
Scope Security provides specialized Managed Detection and Response (MDR) services, exclusively for healthcare organizations. Its core product proactively identifies and neutralizes cyber threats targeting hospitals, clinics, and large provider systems. This cloud-native security solution integrates advanced technology with human expertise, defending critical patient data and operational infrastructure.
The company was founded by Mike Murray, an experienced expert in healthcare cybersecurity. Murray recognized medical institutions faced unique, complex cyber challenges. His insight led to developing a dedicated platform addressing these sector-specific vulnerabilities, bolstering the healthcare industry's defensive capabilities.
Scope Security serves hospitals, clinic networks, and major healthcare provider systems. It provides robust protection against cyberattacks, essential for continuous patient care and safeguarding sensitive information. The company's mission is to enhance healthcare delivery's security, protecting operational integrity for vital public health organizations.
Scope Security has raised $20.0M across 1 funding round.
Scope Security has raised $20.0M in total across 1 funding round.
Direct answer: Scope Security is a New York–based cybersecurity company (founded 2019, formerly Iatrosecure) that builds managed detection & response (MDR) and AI-powered security tools focused on healthcare and highly regulated enterprises; it combines monitoring, threat triage and AI analytics to protect clinical systems and patient data. [1][5]
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Notes and limitations
Scope Security has raised $20.0M in total across 1 funding round.
Scope Security's investors include General Catalyst, Thrive Capital.
Scope Security has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2022 | $20.0M Series A | General Catalyst, Thrive Capital |